These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 34093834)

  • 1. C19orf10 promotes malignant behaviors of human bladder carcinoma cells via regulating the PI3K/AKT and Wnt/β-catenin pathways.
    Li S; Mao L; Zhao F; Yan J; Song G; Luo Q; Li Z
    J Cancer; 2021; 12(14):4341-4354. PubMed ID: 34093834
    [No Abstract]   [Full Text] [Related]  

  • 2. LncRNA CARLo-7 facilitates proliferation, migration, invasion, and EMT of bladder cancer cells by regulating Wnt/β-catenin and JAK2/STAT3 signaling pathways.
    Huang H; Fan X; Zhang X; Xie Y; Ji Z
    Transl Androl Urol; 2020 Oct; 9(5):2251-2261. PubMed ID: 33209690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CUL4B promotes bladder cancer metastasis and induces epithelial-to-mesenchymal transition by activating the Wnt/β-catenin signaling pathway.
    Mao XW; Xiao JQ; Xu G; Li ZY; Wu HF; Li Y; Zheng YC; Zhang N
    Oncotarget; 2017 Sep; 8(44):77241-77253. PubMed ID: 29100384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-regulated MAC30 expression inhibits breast cancer cell invasion and EMT by suppressing Wnt/β-catenin and PI3K/Akt signaling pathways.
    Qu T; Zhao Y; Chen Y; Jin S; Fang Y; Jin X; Sun L; Ma Y
    Int J Clin Exp Pathol; 2019; 12(5):1888-1896. PubMed ID: 31934012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. WHSC1 promotes wnt/β-catenin signaling in a FoxM1-dependent manner facilitating proliferation, invasion and epithelial-mesenchymal transition in breast cancer.
    Zhang J; Lu J; Chen Y; Li H; Lin L
    J Recept Signal Transduct Res; 2020 Oct; 40(5):410-418. PubMed ID: 32314642
    [No Abstract]   [Full Text] [Related]  

  • 6. Downregulation of microRNA-1469 promotes the development of breast cancer via targeting HOXA1 and activating PTEN/PI3K/AKT and Wnt/β-catenin pathways.
    Zhang Y; Fang J; Zhao H; Yu Y; Cao X; Zhang B
    J Cell Biochem; 2019 Apr; 120(4):5097-5107. PubMed ID: 30320894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DUXAP10 inhibition attenuates the proliferation and metastasis of hepatocellular carcinoma cells by regulation of the Wnt/β-catenin and PI3K/Akt signaling pathways.
    Han K; Li C; Zhang X; Shang L
    Biosci Rep; 2019 May; 39(5):. PubMed ID: 30996112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KIF18B promotes breast cancer cell proliferation, migration and invasion by targeting TRIP13 and activating the Wnt/β-catenin signaling pathway.
    Liu L; Zhang Z; Xia X; Lei J
    Oncol Lett; 2022 Apr; 23(4):112. PubMed ID: 35251343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The long noncoding RNA cardiac hypertrophy-related factor plays oncogenic roles in hepatocellular carcinoma by downregulating microRNA-211.
    Li Y; Li Y; Xu X
    J Cell Biochem; 2019 Aug; 120(8):13361-13371. PubMed ID: 30916824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ING5 inhibits lung cancer invasion and epithelial-mesenchymal transition by inhibiting the WNT/β-catenin pathway.
    Liu XL; Meng J; Zhang XT; Liang XH; Zhang F; Zhao GR; Zhang T
    Thorac Cancer; 2019 Apr; 10(4):848-855. PubMed ID: 30810286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of miR1290 on the growth of endometrial cancer and the related mechanism].
    Shen XC; Sun YQ; Yan L; Zhao XX
    Zhonghua Zhong Liu Za Zhi; 2022 Feb; 44(2):130-138. PubMed ID: 35184456
    [No Abstract]   [Full Text] [Related]  

  • 12. MiR-15 suppressed the progression of bladder cancer by targeting BMI1 oncogene via PI3K/AKT signaling pathway.
    Zhang L; Wang CZ; Ma M; Shao GF
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8813-8822. PubMed ID: 31696468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Knockdown of TRIM26 inhibits the proliferation, migration and invasion of bladder cancer cells through the Akt/GSK3β/β-catenin pathway.
    Xie X; Li H; Pan J; Han X
    Chem Biol Interact; 2021 Mar; 337():109366. PubMed ID: 33549581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NFE2L3 promotes malignant behavior and EMT of human hepatocellular carcinoma (HepG2) cells via Wnt/β‑catenin pathway.
    Ren Y; Wang Y; Hao S; Yang Y; Xiong W; Qiu L; Tao J; Tang A
    J Cancer; 2020; 11(23):6939-6949. PubMed ID: 33123284
    [No Abstract]   [Full Text] [Related]  

  • 15. Long non-coding RNA LSINCT5 inactivates Wnt/β-catenin pathway to regulate MCF-7 cell proliferation and motility through targeting the miR-30a.
    Zhang G; Song W
    Ann Transl Med; 2020 Dec; 8(24):1635. PubMed ID: 33490147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Clinical Relevance and Tumor Promoting Function of C19orf10 in Kidney Renal Clear Cell Carcinoma.
    Lu Y; Liao X; Wang T; Hong X; Li Z
    Front Oncol; 2021; 11():725959. PubMed ID: 34552877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-34a Inhibits Breast Cancer Proliferation and Progression by Targeting Wnt1 in Wnt/β-Catenin Signaling Pathway.
    Si W; Li Y; Shao H; Hu R; Wang W; Zhang K; Yang Q
    Am J Med Sci; 2016 Aug; 352(2):191-9. PubMed ID: 27524218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knockdown of HJURP inhibits non-small cell lung cancer cell proliferation, migration, and invasion by repressing Wnt/β-catenin signaling.
    Wei Y; Ouyang GL; Yao WX; Zhu YJ; Li X; Huang LX; Yang XW; Jiang WJ
    Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3847-3856. PubMed ID: 31115012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo and in vitro effects of microRNA-27a on proliferation, migration and invasion of breast cancer cells through targeting of SFRP1 gene via Wnt/β-catenin signaling pathway.
    Kong LY; Xue M; Zhang QC; Su CF
    Oncotarget; 2017 Feb; 8(9):15507-15519. PubMed ID: 28099945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. UPK1B promotes the invasion and metastasis of bladder cancer via regulating the Wnt/β-catenin pathway.
    Wang FH; Ma XJ; Xu D; Luo J
    Eur Rev Med Pharmacol Sci; 2018 Sep; 22(17):5471-5480. PubMed ID: 30229818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.